Simultaneous eicosanoid profiling and identification by liquid chromatography and hybrid triple quadrupole-linear ion trap mass spectrometry for metabolomic studies in human plasma

LaboratoriumsMedizin

Volumn 33, Issue 6, 2009, Pages 341-348

  Kortz, Linda ^a   Geyer, Roland ^b   Ludwig, Ute ^a   Planert, Mathis ^a   Bruegel, Mathias ^a   Leichtle, Alexander ^a   Fiedler, Georg Martin ^a   Thiery, Joachim ^a   Ceglarek, Uta ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Applied Biosystems   (Switzerland)

Author keywords

Arachidonic acid metabolites; Eicosanoids; Fragment spectra library; Linear ion trap; Tandem mass spectrometry

Indexed keywords

11 HYDROXYICOSATETRAENOIC ACID; 12 HYDROXYICOSATETRAENOIC ACID; 5 HYDROPEROXY 6,8,11,14 ICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 5 OXOEICOSATETRAENOIC ACID; 5,6 DIHYDROXYEICOSATRIENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID DERIVATIVE; ICOSANOID; ISOPROSTANE DERIVATIVE; LEUKOTRIENE B4; LEUKOTRIENE DERIVATIVE; LIPOXIN A; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE B2; THROMBOXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BODY FLUID; CHEMICAL STRUCTURE; HALF LIFE TIME; HUMAN; HYBRID TRIPLE QUADRUPOLE LINEAR ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; MONITORING; PLASMA; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION;

EID: 73549116102     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2009.057     Document Type: Article

References (20)

1. O'Donnell VB, Maskrey B, Taylor GW. Eicosanoids: generation and detection in mammalian cells. Methods Mol Biol 2009;462:5-23.
2. Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. J Lipid Res 2009; 50(Suppl):S423-8.
3. Nicolaou A, Kokotos G. Bioactive lipids. Bridgwater: PJ Barnes & Associates, 2004.
4. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical- catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87:9383-9387
5. Montuschi P, Barnes P, Roberts LJ II. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007;14:703-717
6. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
7. Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal 2008;10:1405-1434
8. Benedetto C, McDonald-Gibson RG, Nigam S, Slater TF. Prostaglandins and related substances: a practical approach. Oxford: IRL Press, 1987.
9. Schwedhelm E, Böger RH. Application of gas chromatography- mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease. Clin Chem Lab Med 2003; 41:1552-1561
10. Berdeaux O, Scruel O, Durand T, Cracowski JL. wIsoprostanes, biomarkers of lipid peroxidation in humans. Part 2: quantification methodsx. Pathol Biol (Paris) 2005;53:356-363 (Pubitemid 40943321)
11. Maskrey BH, O'Donnell VB. Analysis of eicosanoids and related lipid mediators using mass spectrometry. Biochem Soc Trans 2008;36:1055-1059
12. Ceglarek U, Leichtle A, Brugel M, Kortz L, Brauer R, Bresler K, et al. Challenges and developments in tandem mass spectrometry based clinical metabolomics. Mol Cell Endocrinol 2009;301:266-271
13. Murphy RC, Barkley RM, Zemski Berry K, Hankin J, Harrison K, Johnson C, et al. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal Biochem 2005;346: 1-42.
14. Neale JR, Dean BJ. Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 2008;871:72-77
15. Yoshida Y, Kodai S, Takemura S, Minamiyama Y, Niki E. Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal Biochem 2008;379:105-115
16. Cao H, Xiao L, Park G, Wang X, Azim AC, Christman JW, et al. An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. Anal Biochem 2008;372:41-51.
17. Masoodi M, Mir AA, Petasis NA, Serhan CN, Nicolaou A. Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom 2008;22:75-83.
18. Deems RA, Buczynski MW, Bowers-Gentry RC, Harkewicz R, Dennis EA. Detection and quantitation of eicosanoids via high performance liquid chromatography/electrospray ionization mass spectrometry. Methods Enzymol 2007;432: 59-82.
19. Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom 2005;19:1332-1338
20. Gros M, Petrovic M, Barcelo D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 2009;81:898-912.